281 related articles for article (PubMed ID: 32039232)
1. Photodynamic Therapy for the Treatment of Glioblastoma.
Cramer SW; Chen CC
Front Surg; 2019; 6():81. PubMed ID: 32039232
[TBL] [Abstract][Full Text] [Related]
2. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N
J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128
[TBL] [Abstract][Full Text] [Related]
3. INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.
Dupont C; Vermandel M; Leroy HA; Quidet M; Lecomte F; Delhem N; Mordon S; Reyns N
Neurosurgery; 2019 Jun; 84(6):E414-E419. PubMed ID: 30053213
[TBL] [Abstract][Full Text] [Related]
4. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.
Stummer W; Müther M; Spille D
Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988
[TBL] [Abstract][Full Text] [Related]
5. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability.
Bhanja D; Wilding H; Baroz A; Trifoi M; Shenoy G; Slagle-Webb B; Hayes D; Soudagar Y; Connor J; Mansouri A
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444537
[TBL] [Abstract][Full Text] [Related]
7. Using Light for Therapy of Glioblastoma Multiforme (GBM).
Vasilev A; Sofi R; Rahman R; Smith SJ; Teschemacher AG; Kasparov S
Brain Sci; 2020 Jan; 10(2):. PubMed ID: 32024010
[No Abstract] [Full Text] [Related]
8. Photodynamic therapy in glioblastoma: Detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection.
Ferrés A; Di Somma A; Mosteiro A; Topczewski TE; Roldán P; Pedrosa L; Diao D; Pineda E; Sierra À; Enseñat J; González-Sánchez JJ
Front Oncol; 2022; 12():1080685. PubMed ID: 36531012
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy.
Coupienne I; Bontems S; Dewaele M; Rubio N; Habraken Y; Fulda S; Agostinis P; Piette J
Biochem Pharmacol; 2011 Mar; 81(5):606-16. PubMed ID: 21182827
[TBL] [Abstract][Full Text] [Related]
10. First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma.
Akimoto J; Fukami S; Suda T; Ichikawa M; Haraoka R; Kohno M; Shishido-Hara Y; Nagao T; Kuroda M
Brain Tumor Pathol; 2019 Oct; 36(4):144-151. PubMed ID: 31487014
[TBL] [Abstract][Full Text] [Related]
11. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
12. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Albert I; Hefti M; Luginbuehl V
Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells.
Karmakar S; Banik NL; Patel SJ; Ray SK
Neurosci Lett; 2007 Mar; 415(3):242-7. PubMed ID: 17335970
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
15. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
17. The Use of Photodynamic Therapy in the Treatment of Brain Tumors-A Review of the Literature.
Bartusik-Aebisher D; Żołyniak A; Barnaś E; Machorowska-Pieniążek A; Oleś P; Kawczyk-Krupka A; Aebisher D
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296440
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic diagnosis and therapy and the brain.
Kostron H
Methods Mol Biol; 2010; 635():261-80. PubMed ID: 20552352
[TBL] [Abstract][Full Text] [Related]
19. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
[TBL] [Abstract][Full Text] [Related]
20. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
Pellosi DS; Paula LB; de Melo MT; Tedesco AC
Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
